IT201900022545A1 - Metodo per l’identificazione di regioni di legame specifiche di deidrogenasi fad/nadh-dipendenti di mammiferi e/o di microorganismi patogeni per uomo, altri mammiferi e piante, per il disegno di nuovi farmaci - Google Patents
Metodo per l’identificazione di regioni di legame specifiche di deidrogenasi fad/nadh-dipendenti di mammiferi e/o di microorganismi patogeni per uomo, altri mammiferi e piante, per il disegno di nuovi farmaciInfo
- Publication number
- IT201900022545A1 IT201900022545A1 IT102019000022545A IT201900022545A IT201900022545A1 IT 201900022545 A1 IT201900022545 A1 IT 201900022545A1 IT 102019000022545 A IT102019000022545 A IT 102019000022545A IT 201900022545 A IT201900022545 A IT 201900022545A IT 201900022545 A1 IT201900022545 A1 IT 201900022545A1
- Authority
- IT
- Italy
- Prior art keywords
- mammals
- nadh
- humans
- plants
- identification
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
- G16B15/30—Drug targeting using structural data; Docking or binding prediction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biotechnology (AREA)
- Evolutionary Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Theoretical Computer Science (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102019000022545A IT201900022545A1 (it) | 2019-11-29 | 2019-11-29 | Metodo per l’identificazione di regioni di legame specifiche di deidrogenasi fad/nadh-dipendenti di mammiferi e/o di microorganismi patogeni per uomo, altri mammiferi e piante, per il disegno di nuovi farmaci |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102019000022545A IT201900022545A1 (it) | 2019-11-29 | 2019-11-29 | Metodo per l’identificazione di regioni di legame specifiche di deidrogenasi fad/nadh-dipendenti di mammiferi e/o di microorganismi patogeni per uomo, altri mammiferi e piante, per il disegno di nuovi farmaci |
Publications (1)
Publication Number | Publication Date |
---|---|
IT201900022545A1 true IT201900022545A1 (it) | 2021-05-29 |
Family
ID=70154881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102019000022545A IT201900022545A1 (it) | 2019-11-29 | 2019-11-29 | Metodo per l’identificazione di regioni di legame specifiche di deidrogenasi fad/nadh-dipendenti di mammiferi e/o di microorganismi patogeni per uomo, altri mammiferi e piante, per il disegno di nuovi farmaci |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT201900022545A1 (it) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6383790B1 (en) | 1999-01-11 | 2002-05-07 | Princeton University | High affinity protein kinase inhibitors |
US20020099506A1 (en) | 2000-03-23 | 2002-07-25 | Floriano Wely B. | Methods and apparatus for predicting ligand binding interactions |
US20050010368A1 (en) | 1997-06-02 | 2005-01-13 | Ernesto Freire | Method for the prediction of binding targets and the design of ligands |
-
2019
- 2019-11-29 IT IT102019000022545A patent/IT201900022545A1/it unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050010368A1 (en) | 1997-06-02 | 2005-01-13 | Ernesto Freire | Method for the prediction of binding targets and the design of ligands |
US6383790B1 (en) | 1999-01-11 | 2002-05-07 | Princeton University | High affinity protein kinase inhibitors |
US20020099506A1 (en) | 2000-03-23 | 2002-07-25 | Floriano Wely B. | Methods and apparatus for predicting ligand binding interactions |
Non-Patent Citations (15)
Title |
---|
"National Report", 2017, ITALIAN DRUG AGENCY, article "the use of antibiotics in Italy" |
ADAM HEIKAL ET AL: "Structure of the bacterial type II NADH dehydrogenase: a monotopic membrane protein with an essential role in energy generation : Structure of bacterial NDH-2", MOLECULAR MICROBIOLOGY., vol. 91, no. 5, 1 March 2014 (2014-03-01), GB, pages 950 - 964, XP055717247, ISSN: 0950-382X, DOI: 10.1111/mmi.12507 * |
ANDERSON AC: "The process of structure-based drug design", CHEMISTRY & BIOLOGY, vol. 10, no. 9, September 2003 (2003-09-01), pages 787 - 97, XP055080025, DOI: 10.1016/j.chembiol.2003.09.002 |
HARBUT, M.B. ET AL.: "Small molecules Targeting Mycobacterium tuberculosis Type II NADH dehydrogenase Exhibit Antimycobacterial Activity", ANGEW. CHEMIE - INT. ED., 2018 |
HARDS, K.COOK, G.M.: "Targeting bacterial energies to produces new antimicrobials", DRUG RESIST. UPDAT, 2018 |
HEIKAL ET AL.: "Tethering' fragment-based drug discovery to identify inhibitors of the essential respiratory membrane protein type II NADH dehydrogenase", BIOORGANIC MED. CHEM. LETT., 2018 |
IMMING PSINNING CMEYER A: "Drugs, their targets and the nature and number of drug targets", NATURE REVIEWS. DRUG DISCOVERY, vol. 5, no. 10, October 2006 (2006-10-01), pages 821 - 34 |
LU, J: "Inhibition of bacterial thioredoxin reductase: An antibiotic mechanism targeting bacteria lacking glutathione", FASEB J., 2013 |
LUCIA TRISOLINI ET AL: "FAD/NADH Dependent Oxidoreductases: From Different Amino Acid Sequences to Similar Protein Shapes for Playing an Ancient Function", JOURNAL OF CLINICAL MEDICINE, vol. 8, no. 12, 1 December 2019 (2019-12-01), pages 2117, XP055716958, ISSN: 2077-0383, DOI: 10.3390/jcm8122117 * |
MADSEN UKROGSGAARD-LARSEN PLILJEFORS T: "Textbook of Drug Design and Discovery", 2002, TAYLOR & FRANCIS |
MURUGESAN, D. ET AL.: "2-mercapto-quinazolinones as inhibitors of Type II NADH dehydrogenase and Mycobacterium tuberculosis: Structure-Activity relationships, mechanism of Action and absorption, Distribution, metabolism, and extraction Characterization", ACS INFECT. OFF., 2018 |
PETER MAN-UN UNG ET AL: "DFGmodel: Predicting Protein Kinase Structures in Inactive States for Structure-Based Discovery of Type-II Inhibitors", ACS CHEMICAL BIOLOGY, vol. 10, no. 1, 9 December 2014 (2014-12-09), pages 269 - 278, XP055717168, ISSN: 1554-8929, DOI: 10.1021/cb500696t * |
SATHEESHKUMAR SELLAMUTHU ET AL: "Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery", EXPERT OPINION ON THERAPEUTIC TARGETS, vol. 21, no. 6, 15 May 2017 (2017-05-15), UK, pages 559 - 570, XP055716954, ISSN: 1472-8222, DOI: 10.1080/14728222.2017.1327577 * |
SELLAMUTHU, S. ET AL.: "Type-II NADH dehydrogenase (NDH-2): A promoting therapeutic target for antitubercular and antibacterial drug discovery", EXPERT OPIN. THER. TARGETS, 2017 |
TAYLOR M C ET AL: "The structure, organization, and expression of the Leishmania donovani gene encoding trypanothione reductase", MOLECULAR AND BIOCHEMICAL PARASITOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 64, no. 2, 1 April 1994 (1994-04-01), pages 293 - 301, XP025464479, ISSN: 0166-6851, [retrieved on 19940401], DOI: 10.1016/0166-6851(94)00034-4 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201792542A1 (ru) | Способ и конструкции специфического редактирования нуклеиновой кислоты у растений | |
BR112018068249A2 (pt) | formulações e doses de uricase peguilada | |
WO2015006705A3 (en) | Micrornas that silence tau expression | |
BRPI1011934A8 (pt) | Composição | |
EP3561119A4 (en) | HARDENED MARTENSITIC STEEL WITH A LOW STRETCHING RATIO AND EXCELLENT EQUIVALENT STRENGTH AND METHOD OF MANUFACTURING THEREOF | |
EP3842515A4 (en) | NOVEL STRAIN OF CUTIBACTERIUM GRANULOSUM, AND COMPOSITION COMPRISING SUCH STRAIN OR CULTURE OF SUCH STRAIN FOR PREVENTING OR TREATING ACNE | |
ZA202004021B (en) | Modified homoserine dehydrogenase, and method for producing homoserine or homoserine-derived l-amino acid using same | |
MX2022007436A (es) | Inhibidores de la autotaxina y sus usos. | |
EP3521478A4 (en) | SILICON STEEL PRODUCT WITH LOW IRON LOSS FOR LOW-NOISE TRANSFORMER AND MANUFACTURING METHOD THEREFOR | |
EP3926194A4 (en) | STIFF ENHANCEMENT MECHANISM FOR MAGNETIC SUSPENDED BEARING, MAGNETIC SUSPENDED BEARING AND BLOOD PUMP | |
BR112018070578A2 (pt) | composições, sistemas, kits, e métodos para tratar uma infecção | |
BR112017006014A2 (pt) | endófitos bacterianos para biocontrole de fungos | |
EP3875616A4 (en) | STEEL SHEET, ELEMENT AND MANUFACTURING PROCESS FOR IT | |
SG11202103103TA (en) | Gdsl lipase, genetically-engineered bacteria and application thereof | |
SG10201913513TA (en) | Method of providing biological data, method of encrypting biological data, and method of processing biological data | |
EP4272827A3 (en) | Method of treating epilepsy | |
PH12017500461A1 (en) | Humanized monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase | |
WO2017035176A8 (en) | Method of preventing or treating obesity with an emc10 inhibitor | |
EP3889293A4 (en) | SHEET STEEL WITH EXCELLENT TENACITY OF AREA AFFECTED BY HEAT AND ITS MANUFACTURING PROCESS | |
SG11202111575WA (en) | Engineered microorganisms and methods for improved aldehyde dehydrogenase activity | |
PH12021551223A1 (en) | Decarboxylase inhibitors for treating parkinson`s disease | |
EP3766999A4 (en) | MARTENSITIC STAINLESS STEEL SHEET, METHOD OF MANUFACTURING THEREOF, AND SPRING ELEMENT | |
BR112017016194A2 (pt) | método | |
MX2019001225A (es) | Compuesto aromatico heterociclico nitrogenoso, metodo de preparacion del mismo, composicion farmaceutico del mismo y aplicacion del mismo. | |
IT201900022545A1 (it) | Metodo per l’identificazione di regioni di legame specifiche di deidrogenasi fad/nadh-dipendenti di mammiferi e/o di microorganismi patogeni per uomo, altri mammiferi e piante, per il disegno di nuovi farmaci |